ArTS Archivio della ricerca di Trieste

ZORZET, SONIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.279
EU - Europa 18.857
AS - Asia 15.586
SA - Sud America 5.075
AF - Africa 610
OC - Oceania 405
Continente sconosciuto - Info sul continente non disponibili 24
Totale 64.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.254
CN - Cina 5.538
IT - Italia 4.892
BR - Brasile 2.999
PL - Polonia 1.977
SG - Singapore 1.821
DE - Germania 1.755
ES - Italia 1.581
MX - Messico 1.291
GB - Regno Unito 1.251
JP - Giappone 1.173
FR - Francia 1.144
IN - India 1.084
TR - Turchia 1.020
SE - Svezia 889
UA - Ucraina 804
HK - Hong Kong 790
ID - Indonesia 770
VN - Vietnam 716
RU - Federazione Russa 581
KR - Corea 556
NL - Olanda 553
CA - Canada 505
TW - Taiwan 503
CO - Colombia 488
PT - Portogallo 471
AR - Argentina 461
FI - Finlandia 436
PE - Perù 385
GR - Grecia 348
CL - Cile 347
AU - Australia 338
AT - Austria 270
TH - Thailandia 263
CH - Svizzera 255
BE - Belgio 233
EC - Ecuador 220
IE - Irlanda 209
RO - Romania 200
SA - Arabia Saudita 188
DK - Danimarca 166
PK - Pakistan 153
EG - Egitto 145
BG - Bulgaria 144
IR - Iran 142
IL - Israele 117
MA - Marocco 106
CZ - Repubblica Ceca 104
MY - Malesia 98
HU - Ungheria 88
PH - Filippine 80
HR - Croazia 77
ZA - Sudafrica 77
SI - Slovenia 69
IQ - Iraq 68
RS - Serbia 65
NZ - Nuova Zelanda 64
VE - Venezuela 63
TN - Tunisia 57
LT - Lituania 54
BD - Bangladesh 52
NO - Norvegia 51
LB - Libano 50
LV - Lettonia 49
PA - Panama 45
BO - Bolivia 42
JO - Giordania 42
AE - Emirati Arabi Uniti 40
KZ - Kazakistan 39
CR - Costa Rica 38
UY - Uruguay 36
GT - Guatemala 35
SK - Slovacchia (Repubblica Slovacca) 35
DZ - Algeria 32
NG - Nigeria 31
UZ - Uzbekistan 30
QA - Qatar 28
PY - Paraguay 27
LK - Sri Lanka 25
HN - Honduras 23
NP - Nepal 23
PS - Palestinian Territory 23
SN - Senegal 21
CY - Cipro 20
BY - Bielorussia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
EE - Estonia 17
GE - Georgia 17
OM - Oman 17
DO - Repubblica Dominicana 16
KE - Kenya 16
MD - Moldavia 16
NI - Nicaragua 16
AL - Albania 12
AZ - Azerbaigian 12
BA - Bosnia-Erzegovina 12
KW - Kuwait 12
MO - Macao, regione amministrativa speciale della Cina 12
PR - Porto Rico 12
Totale 64.576
Salva come PNG Salva come JPEG
Città #
Ashburn 8.912
Warsaw 1.499
Singapore 1.097
Germantown 1.013
Woodbridge 943
Ann Arbor 899
Fairfield 792
Houston 684
Beijing 625
Jacksonville 611
Milan 609
Chandler 574
Rome 537
San Jose 515
São Paulo 501
Hong Kong 499
Wilmington 463
Trieste 454
Madrid 409
Seattle 391
Shanghai 365
Guangzhou 342
Dallas 331
Istanbul 303
Seoul 303
Tokyo 301
Cambridge 289
Chicago 274
Hefei 273
Los Angeles 257
Rio de Janeiro 251
Lima 250
Barcelona 248
Munich 244
Paris 239
Taipei 232
Princeton 226
Ho Chi Minh City 225
Bogotá 213
Frankfurt am Main 210
Hangzhou 207
New York 194
Dublin 187
Hanoi 187
Athens 184
Buenos Aires 183
Boardman 181
Santiago 179
Jakarta 175
Moscow 173
Lisbon 169
Helsinki 164
Vienna 161
Izmir 160
Ankara 154
Naples 148
The Dalles 146
Chengdu 145
Bangkok 142
Columbus 141
Turin 140
Amsterdam 138
Bologna 136
Bengaluru 135
London 131
Sofia 127
Florence 126
Nanjing 119
Curitiba 113
Brasília 111
Zgierz 108
Berlin 105
Medellín 105
Chennai 102
Lauterbourg 101
Hyderabad 100
Melbourne 100
Mumbai 99
Valencia 97
Zurich 97
Las Vegas 96
Sydney 95
Wuhan 95
Brussels 93
Santa Clara 92
Copenhagen 90
Quito 89
Porto Alegre 88
Verona 88
Buffalo 87
Guadalajara 87
Porto 87
Thessaloniki 87
Benito Juarez 86
Goiânia 86
Dearborn 85
Montreal 85
Toronto 85
Belo Horizonte 84
Washington 84
Totale 34.842
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.738
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 856
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 504
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 471
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 441
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies 418
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 409
Photosensitizing Activity of Pegylated Pheophorbide a 379
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 342
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 334
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 304
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 288
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 270
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 261
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 244
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results 241
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 236
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 233
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 231
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 225
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 224
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 220
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 218
Complessi di Rutenio con elevata attività antitumorale 208
Complessi trans di rutenio come agenti antineoplastici 205
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 204
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 201
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 201
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 200
Stress and chemotherapy. Combined effects on tumor progression and immunity in animal models 199
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 195
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 194
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 193
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 192
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 190
Inhibition of B16 Melanoma Metastases with the Ruthenium Complex Imidazolium trans-Imidazoledimethylsulfoxide-tetrachlororuthenate and Down-Regulation of Tumor Cell Invasion. 189
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 187
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 184
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells. 183
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 183
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. 182
Conjugated PDT drug. Phptosensitizing activity and tissue distribution of PEGylated pheophorbide a 177
Tumour metastatic potential after treatment with selective antimetastatic drugs 175
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 174
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 173
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 172
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 172
Cis- and trans-dihalotetrakis(dimethylsulfoxide)Ruthenium(II) Complexes (RuX2(Me2SO)4; X = Cl, Br): Synthesis, Structure and Antitumor Activity 170
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. 169
Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung arcinoma 169
Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors 168
Ruthenium complexes with high antitumoral and antimetastatic activities 167
Ruthenium dimeric compounds suitable as antimetastatic and antineoplastic agents 165
Activity and inhibition by cytotoxic antimetastatic drugs of cathepsin B-like cysteine proteinases in transplantable leukemias in mice 165
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 163
PHOTOSENSITIZING ACTIVITY OF PEGYLATED PHEOPHORBIDE a 162
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 159
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice 159
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: an in vitro study 158
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 158
Metal complexes of platinum group: the promising antitumor features of cis-dichlorotetrakis(dimethylsulfoxide)Ru(II) (cis- RuCl2(DMSO)4) and related complexes 155
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 153
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 149
Antineoplastic Activity of planar Rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia 149
Coordination metal complexes of Rh(I), Ir(I) and Ru(II): recent advances on antimetastatic activity on solid mouse tumors 147
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But 146
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity 144
Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 144
Role of host responses in the drug treatment of metastasis 143
Ruthenium complexes with anti-neoplastic agent 142
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice. 142
Synthesis and Chemical-Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl [1,2,4]triazolo [1,5-a]pyrimidine) 141
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. 141
Antimetastatic properties and DNA interactions of novel class of dimeric Ru(III) compounds Na2[trans-RuCl4(Me2SO)2(μ-L)] (L=ditopic, non chelating aromatic N-ligand). A preliminary investigation 141
The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis 140
Is effectiveness of cancer chemotherapy influenced by stress? 137
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 136
DTIC e i suoi derivati: farmaci citotossici o antimetastatici? 134
Nitric oxide-mediated activity in anti-cancer photodynamic therapy 133
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells. 133
Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins 131
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 131
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic drugs 130
null 127
Melatonin administration in tumor-bearing mice (intact and pinealectomized)in relation to stress, zinc, thymulin and IL-2. 126
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs. 126
Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. 125
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A 124
Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. 122
Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report 122
Synthesis and structure-activity relationships of α-alkylmethylen-2-oxo-chromanes with anticoagulant activity 122
Synthesis of *-Alkylmethylen-2-oxo-chromanes with anticoagulant activity and *-Alkylmethylen-*-lactones from 3-Diethylphosphono-3,4-dihydrocoumarins, 3-Diethylphosphonolactones and Aldehydes. Part 2' 121
Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines 121
Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study 120
Tumour cell uptake, G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells 119
Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing Lewis lung carcinoma. 118
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for thePhotodynamic Therapy 118
The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection. 118
null 117
Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis lung carcinoma treated with proteinase inhibitors 112
Totale 64.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 0 0 0 0 197 80 159
2021/20221.585 67 111 90 179 25 124 57 106 214 149 81 382
2022/20231.795 180 229 141 235 186 307 25 163 212 23 68 26
2023/2024974 72 61 79 59 109 76 134 201 15 37 67 64
2024/202520.679 43 62 165 182 235 231 194 175 376 203 5.865 12.948
2025/202630.996 5.561 4.915 5.671 5.180 4.993 2.280 837 227 606 726 0 0
Totale 65.258